Tenex Health said today it won FDA 510(k) clearance for its TX2 MicroTip designed to treat tendinosis of the shoulder and hip. The Lake Forest, Calif.-based company said that the new TX2 MicroTip is 2 inches longer than the previous TX1 incarnation, allowing for easier access to both the shoulder and hip. “The TX System […]
Tenex Health Inc.
Teleflex (NYSE:TFX) named Thomas Powell CFO effective March 9, replacing Richard Meier, who was ousted the same day.
Powell joined the Limerick, Pa.-based device maker last year as senior vice president of global finance, according to regulatory filings, prior to which he was CFO of TomoTherapy, which was subsequently sold to Accuray (NSDQ:ARAY).
By Thomas Lee
Tenex Health Inc. raised $1.3 million from the sale of equity, according to a filing with the Securities & Exchange Commission.
The Rochester, Minn.-based biotech start-up, which is seeking a total of $2 million, is developing treatments for sports-related injuries such as tendinitis.
Founder and CEO Jagi Gill did not return a phone call seeking comment.